TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Postural control during gait initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective pain assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of pulp vitality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of root development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of the size of periapical radiolucency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Natriuretic peptide plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of stent struts uncovered and/or malapposed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Closure success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Who Required Cervix Dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of children diagnosed as osteogenesis imperfecta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in glucose dynamic profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: toxicity induced by the combination of therapies
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients Enrolled and Receiving Injection
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in neurodevelopmental scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Survival of neonates/infants at discharge
Endpoint domain: Mortality/survival
Primary endpoint: Total pathological complete response (tpCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Days on Anticoagulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proviral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor blood flow measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood antioxidant status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Lipid and protein peroxidation indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: In vitro mitochondrial respiration, enzymatic activities and calcium release parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Phosphorylated Vasodilator Stimulated Phosphoprotein (P-VASP) assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with HCC recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Number of CD8+ Ki67+ T cells found in resected tumour from subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Mean Pain Scale Rating
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Composite incidence of major and minor bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Time-matched Change From Baseline in QTc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Erectile Function (EF) domain score of the International Index of Erectile Function (IIEF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cavernosal artery peak systolic and end diastolic velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major adverse coronary event
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Clinical Malaria Episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Auditory hallucinations severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive value of lung ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: incidence of lower limb phantom pain
Endpoint domain: Adverse events/effects
Primary endpoint: adherence rates to Tecfidera
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Knowledge of dental students towards COVID-19
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attitude of dental students towards COVID-19
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Practice of dental students towards COVID-19
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of patients with myocardial ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Modified Observers Assessment of Alertness/Sedation (MOAA/S) Score 2 Minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Observers Assessment of Alertness/Sedation (MOAA/S) Score 4 Minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful localization of breast tumor and axillary lymph node
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: painDetect Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Percent Change in Fasting LDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intra operative identification of marked node
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of pulmonary nodules detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Serum folic acid status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: B and T cell subsets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total IgG, IgM and IgA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody-secreting cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: AID and BCL-6 production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of medication ordering and monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Activities of Daily Living Abilities Test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Naso-alveolar fistula occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Change in dysexecutive functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in memory knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: meibomian gland function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular Surface Disease Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sleep wake disorder
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Minute ventilation (L/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of at least one clinical or electrical epileptic seizure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Health workers knowledge scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health workers skills scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Major Adverse Cardiac Events (MACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Crohn's disease activity index (CDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Combat Trauma-related Nightmares
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Global Trauma-related Symptom Severity and Functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in OA symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery from COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to ICU care or ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total number of genes associated with the risk of AD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superior mesenteric artery velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: rate of drug absorption (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in the mRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in HDL Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of Allograft rejection
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma Docosahexaenoic Acid (DHA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of Greater Than or Equal to Grade 3 Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: rating of online training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Posture modification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained virus response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline in the Average Pain Intensity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinnitus Handicap Inventory (THI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Tinnitus Magnitude Index (TMI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of resistant bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of patients correctly following the diagnosis algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change of sitting Systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Auditory cortical responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurogenic Bowel Dysfunction Score (NBDs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Responses to the Botvinick Cohen questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Answers on the location of auditory stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal urethral closure pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Increase in urethral pressure during maximal muscle contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Urethral hypermobility on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in hemagglutination inhibition (HAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in microneutralization (MN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Global Health Questionnaire GHQ-12 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Brain inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean percent decrease in serum uric acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overnight change in objective motor performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of SAR-COV2 infection development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: American Shoulder and Elbow Surgeons (ASES) shoulder score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in target lesion severity score (TLSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: symptom-limited exercise test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Total Telotristat Ethyl, LP-778902 and LP-951757
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Observed Plasma Concentration (Tmax) of Total Telotristat Ethyl, LP-778902 and LP-951757
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve From Time 0 to Infinity (AUC0-inf) of Total Telotristat Ethyl, LP-778902 and LP-951757
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay between first draining and end of bandage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes in patient asthma outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Willingness of clinicians to participate in the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Willingness of patients to use the provided material
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Willingness of practices to be randomised
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in gut permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Craving frequencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of CD20 protein and messengerRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUClast of gabapentin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety assessed by AEs
Endpoint domain: Adverse events/effects
Primary endpoint: CGM time spent in target glycaemic range overnight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CGM time spent in target glycaemic range from 2000h-0800h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in cannabis craving scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: serum levels of soluble TWEAK
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound Power Doppler Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: DAS28
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Frequency of Headache Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive function variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Efficacy of high dose therapy and autologous hematopoietic cell transplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Survey of Activities and Fear of Falling in the Elderly (SAFE)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: IgG4 measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Perceived Swallowing Effort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent of Participants With Adverse Events Related to ACAM2000 Vaccine Administration
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of IRE ablation measured by histopathologic examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of device and procedural adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Size Error in Millimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total CD34 cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: T and B lymphocyte counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Abnormal Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal ECG Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Abnormal clinical laboratory results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hydromorphone Plasma Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Data Collection completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Normalisation of maternal serum concentration of bile salts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Normalisation of maternal serum concentration of liver enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: local pain (scores greater than 3 in the analogic visual scale of pain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microbiologically diagnosed flu (yes/no)
Endpoint domain: Adverse events/effects
Primary endpoint: AUC(0-tau) of CNV1014802 and a drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of CNV1014802 and a drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Total recovery at three months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of chikungunya virus-specific immunoglobulin G antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in CDAI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Specific Grade 2 or Higher Skin Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Non-Routine Healthcare Utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Transition Readiness
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentages of correct responses in Neuropsychological tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction times in Neuropsychological tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: baseline-corrected maximum serum concentrations of total testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: baseline-corrected maximum serum concentrations of free testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: baseline-corrected AUCτ of total testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: baseline-corrected AUCτ of free testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cognitive Task Activity Log (CTAL)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Tooth color
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in ACL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Anti-Evolocumab Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Doses Missed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in perceived stress ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in the Fecal Incontinence Quality of Life Scale (FIQoLs)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quantitative contamination of intraluminal fluid from central venous catheters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: blood loss during labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Plasma Proopiomelanocortin (POMC) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: methemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: symptom questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Side effects of pain medication
Endpoint domain: Adverse events/effects